Copyright © 2009  by "International Journal of Pharmaceutica Research and Development"  ·  All Rights reserved  ·  E-Mail: info@ijprd.com
Welcome to "International Journal of Pharmaceutical Research and Development"  i.e. "IJPRD"
HOW TO PREPARE   
YOUR PAPER
What's New | Feedback | Copyright and Disclaimer
Past Issues

March 2009

April 2009

May 2009

June 2009

July 2009

August 2009

September 2009

October 2009

November 2009


December 2009
Online Since : March 2009
Only 10 Articles will be Published in Each Issues
TODAY IS
Abstract Content
Model Abstract
Summary Content
Model Summary

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Article No 1
September -2009 / Volume -
1 / Issue - 7/Article No - 1 / Research Article

DESIGN AND EVALUATION OF AMLODIPINE BESILATE  TRANSDERMAL PATCHES CONTAINING FILM FORMER




HEMANGI J. PATEL1*, JITENDRA S. PATEL1,
B. G. DESAI2, KEYUR D. PATEL3

September - 2009 / Volume - 7
( Total Articles =09 )
IJPRD
Mrs.Patel Hemangi
1Department of Pharmaceutics,
H.N. Shukla pharmacy  College, Rajkot-360002,India.
2KLES’S College of Pharmacy, Bangalore-560010,India
3Visveswarpura Institute of Pharmaceutical Sciences, Bangalore,India
Email:
jiturx@gmail.com
ABSTRACT


Matrix type Transdermal drug delivery system of Amlodipine besilate, an antihypertensive drug were prepared using different polymers like Carbopol 934, 940, HydroxyPropyl Methyl Cellulose and Eudragit L100 in varied ratios. The present study aims to formulate and evaluate Transdermal drug delivery for sustained release of Amlodipine besilate. Physicochemical parameter were characterized. The permeability studies indicates that the drug is suitable for Transdermal drug delivery. The patches were evaluated for various parameters like Thickness, Water-Vapor Permeability, Tensile Strength, Drug Content, Diffusion and Dissolution studies. The patches were further evaluated by DSC and SEM, to ensure uniform distribution of the drug and compatibility of drug with polymer. The Optimized formulation containing Carbopol 934: Eudragit L100 (3:7), with enhancer Hyaluronidase showed 84% drug release after 24 hours. Higuchi and Peppa’s models were used for optimizing the formulation.



Key words:
Transdermal patches; Sustained release; Carbopol; Amlodipine Besilate;
[ VIEW FULL ARTICLE ] [ PDF VIEW ]